AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Revenue
AxoGen Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AxoGen Inc
NASDAQ:AXGN
|
Revenue
$159m
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
31%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is AxoGen Inc's Revenue?
Revenue
159m
USD
Based on the financial report for Dec 31, 2023, AxoGen Inc's Revenue amounts to 159m USD.
What is AxoGen Inc's Revenue growth rate?
Revenue CAGR 10Y
31%
Over the last year, the Revenue growth was 15%. The average annual Revenue growth rates for AxoGen Inc have been 12% over the past three years , 14% over the past five years , and 31% over the past ten years .